Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beijing Foyou Pharma CoSHSE:601089 -0.47%55 Days Payable is 74.81 as of Mar. 2026, which is 55% above its 10-year median of 48.30. GuruFocus rates SHSE:601089 with a GF Score™ of 55/100 and a GF Value™ of ¥16.99 (Fairly Valued). The stock has 1 warning sign investors should review. Among 925 Drug Manufacturers companies, Beijing Foyou Pharma Co ranks worse than 59.68% on this metric.
The historical rank and industry rank for Beijing Foyou Pharma Co's Days Payable or its related term are showing as below:
SHSE:601089'
s Days Payable Range Over the Past 10 Years
Min: 44.29 Med: 48.3 Max: 82.34
Current: 72.61
During the past 8 years, Beijing Foyou Pharma Co's highest Days Payable was 82.34. The lowest was 44.29. And the median was 48.30.
SHSE:601089's Days Payable is ranked worse than 59.68% of 925
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs SHSE:601089: 72.61
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Foyou Pharma Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Foyou Pharma Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Beijing Foyou Pharma Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Beijing Foyou Pharma Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Beijing Foyou Pharma Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Foyou Pharma Co (SHSE:601089) has a Days Payable of 74.81 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Beijing Foyou Pharma Co and its competitors. This is 55% above median its historical median of 48.30. Over the past decade, Beijing Foyou Pharma Co's Days Payable has ranged from 44.29 to 82.34. According to the industry distribution chart, Beijing Foyou Pharma Co ranks #552 out of 925 companies in the Drug Manufacturers industry, placing it in the top 59.7%.
Is Beijing Foyou Pharma Co's Days Payable too high?
Beijing Foyou Pharma Co's current Days Payable of 74.81 is 55% above median its 10-year median of 48.30. Over the past 10 years, this metric has ranged from a low of 44.29 to a high of 82.34. The Drug Manufacturers industry median Days Payable is 90.38. Beijing Foyou Pharma Co's value of 74.81 is 17.2% below this industry median. Based on the distribution chart, Beijing Foyou Pharma Co ranks #552 out of 925 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Beijing Foyou Pharma Co has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Beijing Foyou Pharma Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Beijing Foyou Pharma Co ranks #552 out of 925 companies for Days Payable. This places Beijing Foyou Pharma Co in the lower half of its industry. The industry median Days Payable is 90.38. Beijing Foyou Pharma Co's value of 74.81 is 17.2% below this benchmark. Historically, Beijing Foyou Pharma Co's own Days Payable has ranged from 44.29 to 82.34 over the past decade. While the company's 10-year median is 48.30 vs. the industry median of 90.38, Beijing Foyou Pharma Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Foyou Pharma Co's current Days Payable of 74.81 is 17.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Beijing Foyou Pharma Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Foyou Pharma Co's current Days Payable is 74.81, which is 55% above median its own 10-year median of 48.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Foyou Pharma Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Foyou Pharma Co (SHSE:601089) is currently considered Fairly Valued. The stock's GF Value™ is ¥16.99, compared to a current price of ¥16.77 — trading 1.3% below its estimated fair value. The current Days Payable is 74.81, which is 55% above median its 10-year median of 48.30 and 17.2% below the Drug Manufacturers industry median of 90.38. Beijing Foyou Pharma Co's overall GF Score™ is 55/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Beijing Foyou Pharma Co (SHSE:601089), the current Days Payable is 74.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Foyou Pharma Co (SHSE:601089) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Foyou Pharma Co stock appears to be undervalued.
The current stock price of ¥16.77 is trading 1.3% below its estimated GF Value™ of ¥16.99.
GuruFocus considers Beijing Foyou Pharma Co to be Fairly Valued.
Key valuation signals for SHSE:601089:
Days Payable: 74.81 (55% above median its 10-year median of 48.30)
GF Value™: ¥16.99 vs. price of ¥16.77 (1.3% below fair value)
Industry Position: 17.2% below the Drug Manufacturers median (#552 of 925)
No single metric tells the full story. See the SHSE:601089 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:601089 has been successfully added to your 
